MiNK Therapeutics (INKT)

• Market cap: $42.8M
• 1 day: -6.37%
• 5 days: -41.95%
• 1 month: -18.43%
• 3 months: -23.75%
• 6 months: -37.49%
• Year to date: -17.99%
• 1 year: 7.04%
• 5 years: -92.4%
• 10 years: -92.4%
• Sector: Healthcare
• Industry: Biotechnology

About: MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.

Employees: 23